Teens are reporting struggles with their mental health at unprecedented rates, but resources to help these young people deal with anxiety or depression can be difficult to access.  In this episode, Ashley Knapp, PhD, assistant professor of Psychiatry and Behavioral Sciences, and Robert Simmons, MA, director of social services and public safety at Oak Park Public Library, discuss an innovative community partnership between Northwestern Medicine investigators and a Chicagoland library and how it could be a model for future health interventions.  

Thanks to advancements in synthetic biology, scientists are now engineering bacterial communities with the goal of using these cells to monitor and treat diseases. In this episode, Arthur Prindle, PhD, explains how his lab is reprogramming bacteria that may be used in the future to detect disease and deliver therapeutics for many different conditions, including cancer, diabetes and inflammatory bowel disease.

A new study published in the journal Nature details breakthrough T-cell immunotherapy research from Northwestern Medicine. In this episode, Jaehyuk Choi, MD, PhD, senior author of the paper, explains how a gene mutation found in T-cells of patients with lymphoma could hold the key to a potent cancer-fighting immunotherapy for solid tumor cancers, which account for 90 percent of all cancers. 

When most of us think about dopamine, we think about reward signals. But new research from Northwestern Medicine, published in Nature Neuroscience, has found a genetic subtype of dopamine neurons that do not respond to rewards at all, and instead, fire when the body moves. Rajeshwar Awatramani, PhD, and Daniel Dombeck, PhD led this work. In this episode they explain how the results could change the field of dopamine research

As the primary investigator of The NIH Toolbox®, Richard Gershon, PhD, has led a team of hundreds of scientists to develop and evolve state-of-the-art digital assessments of cognition, motor, sensation and emotion which has been used by clinicians, investigators and academics for nearly two decades.   In this episode, Gershon explains how the third version of The NIH Toolbox® app developed for the iPad, provides test batteries for cognition, motor, emotional and sensory functioning.

Mitochondria are widely known as cellular “powerhouses” for their role in producing energy for cells. But pioneering research from Northwestern Medicine investigators over the last 20 years has proven mitochondria are also major players in lung disease, cancer, brain disease and immune-related diseases. Navdeep Chandel, PhD, a 2023 recipient of the Lurie Prize in Biomedical Sciences by the Foundation for the National Institutes of Health, leads this research. In this episode he discusses how his team’s recent findings could advance the design and implementation of new therapies.  

Northwestern Medicine is dedicated to improving outcomes for patients who are in need of organ transplants. Daniela Ladner, MD, MPH, is leading research that sheds light on the barriers to transplantation as the founding director of the Northwestern University Transplant Outcomes Research Collaborative (NUTORC). She discusses the groundbreaking research that makes Northwestern a leader in organ transplantation.

Both long-term alcohol consumption and binge drinking can speed up biological aging, according to a Northwestern Medicine study published in the journal Aging. Lifang Hou, MD, PhD, chief of Cancer Epidemiology and Prevention in the Department of Preventive Medicine led the study and discusses the link between genetics and lifestyle in the context of preventing disease.  

Mozziyar “Mozzi” Etemadi, MD, PhD, is supporting the transformation of healthcare delivery and patient care at Northwestern Medicine by bringing engineers into direct contact with clinical providers. In this episode, he talks about the explosion of artificial intelligence in healthcare in recent years and how Northwestern Medicine is using this technology to improve healthcare delivery and patient care.  “I think that as some of these tools like ChatGPT become more commonplace, as we learn more how they work, how to create them, we will create somewhat simpler versions of them, I think, that will work well in healthcare because they'll be a human in the loop and they'll be clear interpretability in what these things are saying. And trust will be built gradually.” Mozziyar Etemadi, MD, PhD, assistant professor of Anesthesiology, medical director of advanced technologies at Northwestern Medicine, and chief of data engineering at the Institute for Augmented Intelligence in Medicine.

Treating cancer has become increasingly difficult as cells develop resistance. Northwestern investigators have sought to address this issue on the cellular level through the development of a novel FateMap tool, used to predict the future behavior of cancer cells before they are exposed to cancer-fighting drugs. In this episode, Yogesh Goyal, PhD, discusses his latest research, published in Nature, and how his lab is addressing complex problems through an interdiscplinary approach. 

The launch of the Simpson Querrey Lung Institute for Translational Science (SQLIFTS) at Northwestern University Feinberg School of Medicine aims to expedite the discovery and implementation of innovative lung disease treatments through a patient-centered approach. In this episode, Scott Budinger, MD, the new executive director of the institute, discusses its launch and how it aims to transform lung disease research and clinical care.   

The global prevalence of Parkinson's disease has doubled in the past 25 years. While research into this extremely diverse neurodegenerative disorder is very active, there is much left to be uncovered about the underlying cause of the disease. Recently, Northwestern Medicine investigators have discovered novel genetic factors contributing to the risk of Parkinson's disease, which may lead to potential therapeutic targets. Steven Lubbe, PhD, assistant professor of Neurology at Feinberg, discusses these findings recently published in the journal Brain.

Disrupting our internal clocks can lead to diseases such as obesity and diabetes. Scientists at Northwestern have uncovered the mechanism behind why late-night eating is linked to weight gain and diabetes. Joseph Bass, MD, PhD, led the study published in the journal Science.  He shares the results and details the two decades of work leading to this latest discovery. Bass is chief of the Division of  Endocrinology, Metabolism and Molecular Medicine in the Department of Medicine.

This episode was released in February 2021, and is being re-shared to offer the research behind the popular weight loss drugs Ozempic and Wegovy. Northwestern's Robert Kushner, MD, discusses the drug semaglutide, typically prescribed for treatment of Type 2 diabetes and the results of the phase 3 clinical trial as a treatment for obesity with very promising results. The study was published in the New England Journal of Medicine, and in 2022, Kushner was awarded the prestigious Herbert Pardes Clinical Research Excellence Award from the Clinical Research Forum.

There's strong evidence that physical activity can play an important role in the health and lifespan of cancer survivors. Siobhan Phillips, PhD, MPH, leads the Exercise and Health Lab at Feinberg, which designs, tests, implements and disseminates physical activity interventions to support cancer survivors. In this episode, Phillips details interventions specifically designed for breast cancer survivors, a majority of whom don't meet the recommended standards for weekly physical activity. 

Skin diseases from psoriasis to melanoma affect as many as one in three Americans at any given time. Kathleen Green, PhD, has greatly advanced basic molecular research related to skin diseases. She discusses recent discoveries in her lab that could lead to future therapeutic targets. 

Physicians are notorious for prescribing antibiotics as a "quick fix" when they aren't necessary. There are many reasons why, and Jeffrey Linder, MD, MPH, dives into those and discusses effective ways to reduce the number of inappropriate prescriptions by working with physicians. Originally released in fall 2018, this episode is still timely as the over prescription can lead to dangerous side effects for patients including antibiotic resistance.

Northwestern scientists Yuan Luo, PhD, and Catherine Gao, MD, discuss a study they conducted using the artificial intelligence chatbot, ChatGPT. The results showcase the online tool's ability to produce convincing medical research abstracts. They also discuss the tool’s potential to help with writing-intensive tasks in healthcare and medical research.  

A theoretical neuroscientist, Ann Kennedy, PhD, is investigating neural computation and the structure of behavior. In this episode, she talks about her recent research in the area of aggression and how it's regulated in the brains of animals. She was recently named the winner of the 2022 Eppendorf and Science Prize for Neurobiology.

Parkinson's disease is the second most prevalent neurodegenerative disease, and nearly one million people have Parkinson's disease in the U.S. A $30 million dollar, phase 3 clinical trial at Northwestern is investigating whether exercise can slow Parkinson's disease progression. Daniel Corcos, PhD, a professor of Physical Therapy and Human Movement Sciences, is leading the trial and explains what he hopes to accomplish. Interested in the study? Learn more: https://www.feinberg.northwestern.edu/research/clinical-research/trials/index.html?id=STU00211903

To have the greatest impact on human health, biomedical research findings and evidence-based practices need to be implemented into routine healthcare. What is implementation science, and how can we ensure research successfully makes an impact? Rinad Beidas, PhD, and Sara Becker, PhD, discuss the field and its future as a research priority at Northwestern University Feinberg School of Medicine.

There’s been an uptick in childhood food allergies in recent years, and new evidence from Northwestern shows they’re also becoming more common in adults. Many of the reactions to these allergies are life-threatening. Why is this increase happening, and how can we keep people affected by food allergy safe? Ruchi Gupta, MD, MPH, is trying to answer those questions. This a rewind episode that originally was published in 2019.

A Northwestern Medicine course called Cooking Up Health is giving medical students, trainees and health professionals the opportunity to learn culinary medicine and food-as-medicine science concepts. Melinda Ring, MD, created the course and explains how it can improve the health of patients and train more nutrition-aware physicians.  

Understanding how genes function is a vital part of understanding how to better treat cancer. Research led by Mazhar Adli, PhD, is grounded in the development of a systematic approach to identify the function of each gene in the human body. His team aims to discover novel therapeutic drug combinations to prevent cancer development and chemotherapy resistance. 

Bariatric surgery is proving to be an effective tool to help teenagers with severe obesity lose weight and reverse the progression of weight-related conditions, according to findings from the Teen Longitudinal Assessment of Bariatric Surgery study (Teen-LABS). Thomas Inge, MD, PhD, principal investigator of Teen-LABS, shares results of the study, which is the only multicenter National Institute of Health sponsored research on adolescent bariatric surgery. 

How are habits – both good and bad – formed in the brain, and what role do habits play in diseases of the brain? These are some of the questions neuroscientist, Talia Lerner, PhD, is investigating in her lab. Her recent study, published in Cell Reports, may change the overall understanding of how habits are formed and could be broken.

Uniting scientists and harnessing the power of the immune system to fight disease is at the heart of the new Center for Human Immunobiology at Northwestern University Feinberg School of Medicine. Stephanie Eisenbarth, MD, PhD is leading the new center, she is also the new chief of Allergy and Immunology in the Department of Medicine.   She discusses the variety of immunology research taking place within the new center and its goal of bringing a community of immunologists together to discover and translate innovative science into cures for immune-related diseases. 

In recent years, Feinberg has launched several initiatives to augment human expertise with computational methods and advance the science of human health. Theresa Walunas, PhD, explains how she is using big data from electronic medical records in a variety of projects at Feinberg, from improving quality of care to identifying patients who could develop debilitating autoimmune diseases. 

A celebrated molecular neuroscientist, Jeremy Nathans, MD, PhD, is responsible for landmark discoveries that have changed our understanding of how humans see the world. He is an investigator of the Howard Hughes Medical Institute and professor at Johns Hopkins University School of Medicine.  

Cardiovascular disease (CVD) is the number one cause of death globally, and nearly half of all U.S. adults are currently at risk for heart attack and stroke. Hossein Ardehali, MD, PhD, is working to understand the role of iron and metabolic processes in cardiovascular disease and develop new therapies that target iron accumulation in people with CVD and many other chronic diseases.

Alfred George, Jr., MD, is a pioneer in understanding the mechanisms by which ion channel mutations cause a variety of inherited disorders, such as genetic epilepsy. He discusses his recent breakthroughs in the field and his optimism for future RNA therapeutics to treat rare genetic diseases. 

Cell and Developmental Biology is a field that's integral to finding new therapies for a wide variety of diseases. At Feinberg, Lusia Iruela-Arispe, PhD, a vascular biologist, leads the Department of Cell and Developmental Biology as chair. In this episode, talks about her research and the future of cell-based treatments for diseases.  

Providing evidence-based medical care to transgender and gender nonconforming youth has been a challenge in the past, as trans-related healthcare has long been understudied. Robert Garofalo, MD, MPH, discusses how gender-affirming care can improve the overall health and well-being of transgender and gender diverse children and adolescents. He also discusses his research on the short-term and long-term outcomes of gender-affirming medical treatments.

The past two years have been a crucial time for the study of infectious diseases. Richard D’Aquila, MD, professor of Medicine in the Division of Infectious Diseases at Northwestern and director of NUCATS, discusses how HIV/AIDS research is running parallel to ongoing COVID-19 research with interesting crossover and lessons learned.  

Nearly half of all patients with heart failure have preserved ejection fraction, or HFpEF, yet there is much that is unknown about HFpEF and how to best prevent it and treat it. Northwestern Medicine cardiologist, Sanjiv Shah, MD, leads the world's first clinical program dedicated to the study of heart failure with HFpEF. He discusses latest discoveries on the mechanisms of HFpEF and identifying therapeutic targets for it.  

Music-based medical interventions can have remarkable therapeutic benefits for patients diagnosed with cognitive impairments such as Alzheimer’s disease, dementia and Aphasia. Cognitive Behavioral Neurologist Borna Bonakdarpour, MD, explains how he is using and studying these clinical interventions through the new Northwestern Music and Medicine Program. 

A novel gene therapy promoted transfusion independence in more than 90 percent of adult and pediatric patients with transfusion-dependent beta-thalassemia. Study co-author Jennifer Schneiderman, MD, discusses results, published in the New England Journal of Medicine.

Man's best friend is helping scientists find new treatments for brain tumors. Amy Heimberger, MD, is a board-certified neurosurgeon with extensive training and experience in the field of immunology. She is part of a promising new study in canine glioblastoma that could lead to more effective human glioblastoma clinical trials.

Sachin Patel, MD, PhD, is the new chair and Lizzie Gilman Professor of Psychiatry and Behavioral Sciences at Feinberg and psychiatrist-in-chief at Northwestern Memorial Hospital’s Norman and Ida Stone Institute of Psychiatry. In this episode, he talks about the current mental health crisis in this country, his research and vision for the department. 

According to the CDC, more Americans died of gun-related injuries in 2020 than in any other year on record. Judith Moskowitz, a social psychologist and professor of Medical Social Sciences at Feinberg, talks about how her NIH-funded research and intervention programs will be used to address stress and burnout in Chicago’s front-line violence prevention workers through the READI Chicago program.

David Gate, PhD, assistant professor of The Ken & Ruth Davee Department of Neurology, discusses his study on the detrimental role the immune system plays in Lewy body dementias. Gate’s new research published in Science suggests pathways toward unprecedented treatment therapies for this devastating disease.

Cardiovascular disease is the leading cause of pregnancy-related deaths in the U.S. and according to a new Northwestern Medicine study published in the journal Circulation, about sixty percent of women in the U.S. have poor heart health before becoming pregnant. Study authors Sadiya Khan, MD and Natalie Cameron, MD, explain the results of the study and what needs to be done to reverse this alarming trend.

In response to the first successful animal heart transplant into a human patient, internationally renowned transplant surgeon Satish Nadig, MD, PhD, reviews some of the scientific developments that have culminated in this moment, and stresses the ongoing need for other experimental strategies. Dr. Nadig is also the new director of Feinberg's Comprehensive Transplant Center. 

Gregory Smith, professor of Microbiology-Immunology at Feinberg, has been investigating a path to long-needed vaccine development for herpes virus. He recently published findings in the journal Nature that bring the possibility of a preventive vaccine a step closer. 

Since coming to Northwestern in 2013, Deborah Smith Clements, MD, chair of Family & Community Medicine, has established three thriving family medicine residency programs and has been an advocate for improving the residency match process, health policy and social justice. She talks about her work, leading her department through COVID-19 and her recent Distinguished Service Award from Illinois Academy of Family Physicians.

Immunotherapy has revolutionized cancer treatment over the last few decades, though not for glioblastoma — the most common and deadly malignant brain tumor. However, Northwestern Medicine neurosurgeon Adam Sonabend, MD, shares promising research on the potential benefits of immunotherapy for certain glioblastoma patients.

What do we know about the effectiveness of COVID-19 boosters, and how might they better protect us from new variants such as omicron? Alexis Demonbreun, PhD, assistant professor of Pharmacology, offers insight. She is the author of a new study that shows COVID-19 boosters seem to supercharge antibody response.

Millions of molecular proteins are swimming through our body's cells and many studies have discovered that these proteins are the main drivers of all human diseases. Scientists are now mapping proteins the way the Human Genome Project mapped genes. Northwestern's Neil Kelleher is at the forefront of the Human Proteoform Project and explains how it could lead to more targeted and effective diagnostics and treatments for diseases.

Regenerative nanomedicine is being used to develop new therapies for devastating conditions such as severe spinal cord injuries. Northwestern's Dr. Samuel Stupp is a pioneer in the field of regenerative nanomedicine and recently published a paper in the journal Science that details how a new injectable therapy uses synthetic nanofibers to reverse severe spinal cord injuries in animals and how this therapy could soon be used in humans.

People who are Black make up the largest group of minorities in need of an organ transplant. In 2019, Northwestern Medicine launched the African American Transplant Access Program to help address this problem. Founding director of the program Dinee Simpson, MD, talks about the barriers to organ transplant for Black patients and how she is working to bring down those barriers in Chicago with innovative outreach, community-engaged research and more. 

People who are Black make up the largest group of minorities in need of an organ transplant. That's according to the Office of Minority Health at the U.S. Department of Health and Human Services. In 2019, Northwestern Medicine launched the African American Transplant Access Program to help address this problem.  Dinee Simpson, MD, is the founding director of the program and an Assistant Professor of Surgery in the Division of Organ Transplantation at Feinberg. She talks about the barriers to organ transplant for Black patients and how she is working to bring down those barriers here in Chicago with innovative outreach, community-engaged research and more. 

This spring, the World Health Organization began using the Greek alphabet to label key variants of SARS-CoV-2. The Greek names make it easier to talk about variants with the public, but in the scientific community these variants are being discussed and studied at the molecular level to learn as much as possible about their evolution, replication and mutation. Judd Hultquist, PhD, shares insight on SARS-CoV-2 variants. He is an assistant professor of Medicine in the Division of Infectious Diseases at Feinberg and an HIV scientist whose lab has shifted many resources to study SARS-CoV-2, to track the origin of its variants and also understand how antiviral proteins found in humans can protect against COVID-19 and other viruses.

While there are more treatments now than ever before for neuromuscular diseases like muscular dystrophy, patients who have very specific gene mutations associated with these diseases have few options. Dr. Elizabeth McNally says a discovery in her lab could lead to a new therapy for muscular dystrophy, including its rare forms.

As the Delta variant of SARS-CoV-2 is causing breakthrough infections in some vaccinated people around the world, scientists at Northwestern Medicine are developing and studying potential next-generation COVID-19 vaccines that could be more effective at preventing and clearing breakthrough infections. Pablo Penaloza-MacMaster, assistant professor of Microbiology-Immunology at Feinberg, discusses recent studies from his lab that aim to improve current COVID-19 vaccines. 

Esophageal diseases are extremely common, and symptoms such as trouble swallowing, chest pain, regurgitation and choking diminish quality of life. There can also be psychosocial effects for patients with these diseases that includes hypervigilance — a heightened focus on physical symptoms — and symptom-specific anxiety such as fear of choking. Identifying patients with issues could help providers better treat their disease. That's according to a new Northwestern Medicine study published in the journal Gastroenterology.

A recent survey of more than 32,000 caregivers of Chicago Public School students found that around a quarter children and adolescents were described as stressed, anxious, angry or agitated in the months after remote learning began. Black and Latinx participants experienced significantly more of these stressors. Dr. Tali Raviv, associate professor of Psychiatry and Behavioral Sciences at Feinberg explains the results and offers insight.

Dean Eric G. Neilson, MD, and Robert Murphy, MD, talk about COVID-19 vaccine safety and effectiveness. This conversation was recorded May 7, 2021. 

Recently, the director of the CDC officially recommended that pregnant women receive the vaccines for COVID-19. However, pregnant women are less likely than non-pregnant women to get vaccinated and are at greater risk of hospitalization and death from the disease. Emily Miller, MD, MPH, has been caring for pregnant patients at Prentice Women's Hospital since the onset of the pandemic. She shares results from a new study on the benefit of maternal vaccination and speaks to the history of excluding pregnant women from clinical trials.

A wearable sensor developed by Northwestern University scientists could help better monitor scratching in children with eczema and assess the effectiveness of therapies for eczema and other conditions that cause itch. Steve Xu, MD, explains the results of a study of the sensors published in Science Advances. 

A wearable sensor developed by Northwestern University scientists could help better monitor scratching in children with eczema and assess the effectiveness of therapies for eczema and other conditions that cause itch. Steve Xu, MD, explains the results of a study of the sensors published in Science Advances. 

COVID-19 can be a multi-system disease, impacting many organs and the entire nervous system. Igor Koralnik, MD, has been investigating the neurologic symptoms of the disease and published the first study focused on long-term neurological symptoms in COVID-19 “long haulers.” He explains the study and what he is seeing in the Neuro COVID-19 Clinic at Northwestern Memorial Hospital.

At the beginning of the pandemic, Daniel Batlle, MD, professor of medicine in the Division of Nephrology-Hypertension at Northwestern, proposed a hypothesis that soluble ACE2 could treat the SARS-CoV-2 virus and lead to full recovery and survival. Now, he has exciting preliminary results to share.

Black men are more likely to get prostate cancer and more than twice as likely to die from the disease than other men. Dr. Edward Schaeffer has developed a research team to better understand this problem. In this show he talks about his latest discoveries, which are paving the way to precision medicine for aggressive prostate cancer. Dr. Schaeffer is the Chair of the Department of Urology at Northwestern and a Northwestern Medicine urologist with a specialized practice in prostate cancer. 

An early clinical trial in individuals with the deadly brain cancer glioblastoma showed an experimental spherical nucleic acid drug developed by Northwestern University scientists was able to penetrate the blood-brain barrier and trigger the death of tumor cells. Lead investigator Priya Kumthekar, MD, explains the results of the study.

COVID-19 vaccines are being doled out across the nation, almost exclusively to adults. Pfizer's vaccine has been authorized for ages 16 and up and Moderna's vaccine for 18 and up. So when might younger children be vaccinated for COVID-19? And what needs to happen before then? Northwestern's William Muller, MD, PhD, offers insight. 

The drug semaglutide, typically prescribed for treatment of Type 2 diabetes, was used in a phase 3 clinical trial as a treatment for obesity with very promising results. Northwestern's Robert Kushner, MD, led this study, recently published in the New England Journal of Medicine and shares the results.

Since SARS-CoV-2 was discovered in Illinois over a year ago, Northwestern scientists have been tracking the evolution of the disease in the Chicago area. Ramón Lorenzo-Redondo, PhD, research assistant professor of Medicine in the Division of Infectious Diseases, is part of the team leading this work. He talks about the team's research, the new COVID-19 variants and how the vaccines on the market today stand up to them.

Mercedes Carnethon, PhD, a Northwestern Medicine epidemiologist and a population science expert, talks about how COVID-19 is affecting Black, Indigenous, Latinx and other people of color the most, as the pandemic continues and vaccine rollouts lag behind.

In this episode, host Erin Spain takes a look and listen back on some of the top Feinberg research published in 2020. Hear how Northwestern scientists responded to COVID-19 while publishing high-impact papers unrelated to the pandemic and making vital discoveries across the research enterprise during a difficult time.  

Ankit Bharat, MBBS, Chief of Thoracic Surgery at Northwestern Medicine and director of the Lung Transplant program, shares findings that support why lung transplantation should be considered for patients who have developed irreversible lung disease due to COVID-19.

A $30 million dollar, phase 3 clinical trial is about to begin at Northwestern, investigating whether exercise can slow Parkinson's disease progression. Daniel Corcos, PhD, a professor of Physical Therapy and Human Movement Sciences is leading the trial and explains what he hopes to accomplish.

A new Northwestern Medicine study shows patients whose colon cancer surgery was performed by a highly skilled surgeon had a 70 percent lower risk of dying over five years compared to patients with a lower skilled surgeon. 

A Swiss Amish community in Indiana has been the focus of ongoing studies led by Dr. Douglas Vaughan, chair of the Department of Medicine at Northwestern. Many members of this Amish community have a gene mutation that appears to protect against biological aging in a variety of ways.  A new experimental drug that effectively lowers the level of the protein associated with this mutation is now being tested as a treatment for people with COVID-19, in a phase 2 clinical trial at Northwestern.

As flu season begins and COVID-19 continues to spread, Michael Ison, MD, is here to share some of his latest findings. He is part of Northwestern research teams running studies on both COVID-19 and on influenza vaccines and treatments.

A new Northwestern Medicine study published in JAMA Pediatrics has revealed that more stringent negligence laws, which hold adults responsible for safe storage of firearms, may have potential to reduce firearm fatalities in children. Hooman Azad, a third-year medical student at Feinberg and first author of the study explains.    

Most people with peripheral artery disease, PAD, have great difficulty walking and few treatments to help. Preliminary results of a new Northwestern Medicine study suggest that cocoa may have a therapeutic effect on walking performance in people with PAD. Dr. Mary McDermott led this study and shares the results.

When we read about college and youth sports today, it's usually about the dangers to health - mainly, concussions. However, a new study led by Nina Kraus, PhD, director of Northwestern's Auditory Neuroscience Laboratory, BrainVolts, has found that athletes have healthier brains than non-athletes. 

In this bonus episode, Clyde Yancy, MD, and Donald Lloyd-Jones, MD, ScM, offer tips for people to consider in the new year, that can improve their health. Lloyd-Jones suggests experimenting with different tactics to lose or maintain weight, such as intermittent fasting.  "The important thing, if you need to lose weight, is to find out what works for you. It doesn't really matter how you do it, as long as you do it," Lloyd-Jones says. "75 percent of Americans are overweight or obese; we are the fattest nation there has ever been. It is not anyone's fault, but it is something we have to do something about." If losing weight feels like an overwhelming goal, Lloyd-Jones suggests people concentrate on not gaining any additional weight instead. Yancy often quotes to his patients a phrase coined by Northwestern physician Neil Stone, MD: "eat less, do more and know your numbers (such as blood pressure)." But Yancy says he would add one more idea to that phrase: maintain a healthy social life.  "Remain engaged with people who matter to you and people for whom you matter, because it looks like it can add years to your life expectancy and cognitive function," he says. 

For those with advanced metastatic prostate cancer, treatments are limited, but a new phase 3 international trial shows that a genetically targeted therapy could offer new hope for patients with specific gene mutations in their tumors. Northwestern's Maha Hussain, MD, recently presented the results of this landmark trial and shares her insight.

For three decades, Ali Shilatifard, PhD, has dedicated his career to revealing the causes of childhood leukemia and providing detailed molecular insight into the role of epigenetics in cancer. He hopes his discoveries will lead to a super drug that could end childhood leukemia and other cancers.

Northwestern scientists are conducting dozens of experiments and clinical trials aimed at understanding and fighting glioblastoma, the most common and aggressive primary brain tumor in adults. Rimas Lukas, MD, shares results of a promising Phase 1 clinical trial and other projects underway. 

Mozziyar Etemadi, MD, PhD, a research assistant professor in Anesthesiology and Biomedical Engineering is leading deep learning projects in his lab at Northwestern. He talks about a collaboration between Northwestern and Google that uses a deep learning system to predict lung cancer.

Every member of the Northwestern University Feinberg School of Medicine community has a voice and a perspective uniquely their own. Check out our new essay-style podcast Feinberg Perspectives, where faculty, trainees and students read pieces they’ve written themselves, using their voices to share messages, stories and insights into their lives and the field of healthcare.

In the new Louis A. Simpson and Kimberly K. Querrey Biomedical Research Center at Northwestern, tiny bio-artificial kidneys are growing in the lab of Dr. Susan Quaggin. She and a team of scientists, with expertise in stem cells, blood vessels and developmental biology, are accelerating the development of such bioengineered organs. But that’s not all. Dr. Quaggin talks about the projects and science underway that could lead to new treatments to prevent, manage and cure kidney diseases.

Results from a randomized phase three clinical trial published in The New England Journal of Medicine could change the way women are treated for later stage endometrial cancer. Northwestern's Dr. Daniela Matei led the trial and is here with details. 

Death rates due to heart failure are increasing, especially in people under the age of 65 and specifically among Black men. What is fueling this upturn? How can it be stopped? Sadiya Khan, MD, assistant professor of medicine explains.

As we age, almost all of us have some memory loss. This age-related affliction is normal, but a new Northwestern Medicine study suggests it can be improved with non-invasive brain stimulation that sends electromagnetic pulses into a specific area of the brain. Joel Voss, PhD, an associate professor at Northwestern, led this study, published in the journal Neurology.

A new approach from the field of ophthalmology shows promise in detecting non-invasive biomarkers of mild cognitive impairment, the precursor to Alzheimer’s disease. Northwestern's Amani Fawzi, MD, explains.

A large, new Northwestern Medicine study reports adults who ate more eggs and dietary cholesterol had a significantly higher risk of cardiovascular disease and death from any cause. Norrina Allen, associate professor of preventive medicine at Northwestern University Feinberg School of Medicine, explains.

The health issues facing people with severe eczema are not only skin deep. Aside from intense itching and dry, irritable skin, people with a type of eczema known as atopic dermatitis also have significantly higher rates of medical and mental health issues. Why does atopic dermatitis come with so many other health issues and what can be done to give patients relief? Northwestern's Dr. Jonathan Silverberg explains.